James H Lewis

5PUBLICATIONS
19CO-AUTHORS
Reaction engineering (excl. nuclear reactions)Characterisation of biological macromoleculesCancer therapy (excl. chemotherapy and radiation therapy)Medical biochemistry - amino acids and metabolitesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 17, 2026
Correction: Liver Safety of the Dual Neurokinin‑1/‑3 Receptor Antagonist Elinzanetant.

|Mar 18, 2026
Liver Safety of the Dual Neurokinin-1/-3 Receptor Antagonist Elinzanetant.

James H Lewis, Raúl J Andrade, Dominique Larrey

|Dec 04, 2025
Hepatic Effects, Potential Drug-Induced Liver Injury, and Other Liver Safety Considerations of Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in the New Era of Expanding Non-oncology Indications: Literature Review and Expert Consensus.

Anna Fettiplace, Arie Regev, Alexandre Kiazand

|Jun 02, 2025
Managing Aminotransferase Elevations in Patients with Friedreich Ataxia Treated with Omaveloxolone: A Review and Expert Opinion on Use Considerations.

Susan Perlman, Mathieu Anheim, Sylvia Boesch

|Jun 29, 2020
Onapristone Extended Release: Safety Evaluation from Phase I-II Studies with an Emphasis on Hepatotoxicity.

James H Lewis, Paul H Cottu, Martin Lehr

Pageof 1

Frequent Collaborators

3 joint publications

Dominique Larrey

2 joint publications

Richard A Anderson

2 joint publications

Esther Groettrup-Wolfers

2 joint publications

Yves Horsmans